In Karakalpakstan, a semi-autonomous region of Uzbekistan, MSF has been running a project treating multidrug-resistant tuberculosis (MDR-TB) since 2003. MDR-TB is a debilitating disease and requires lengthy treatment with a complex combination of toxic drugs, which often have appalling side effects.